Catalog No.
PHK03501
Species reactivity
Human
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human KLK4 (Ser27-Ser254).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
PRSS17, KLK4, KLK-L1, Prostase, PSTS, Serine protease 17, Enamel matrix serine proteinase 1, Kallikrein-4, Kallikrein-like protein 1, EMSP1
Purification
Purified by antigen affinity column.
Accession
Q9Y5K2
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Allosteric Anti-KLK4 Antibody Development for Targeted Anti-cancer Effects in Ovarian Carcinoma., PMID:40154917
Epitope mapping of anti-amelogenin IgA in coeliac disease., PMID:32084301
Pseudogene Associated Recurrent Gene Fusion in Prostate Cancer., PMID:31446281
Potential function of TGF-β isoforms in maturation-stage ameloblasts., PMID:30929801
Kallikrein-related peptidases represent attractive therapeutic targets for ovarian cancer., PMID:30114962
Identification of methylation sites and signature genes with prognostic value for luminal breast cancer., PMID:29642861
Tissue kallikrein-related peptidase 4 (KLK4), a novel biomarker in triple-negative breast cancer., PMID:28755528
Kallikrein-related peptidase 4 induces cancer-associated fibroblast features in prostate-derived stromal cells., PMID:28510269
Androgen Receptor Involvement in Rat Amelogenesis: An Additional Way for Endocrine-Disrupting Chemicals to Affect Enamel Synthesis., PMID:27684650
Quantification of Human Kallikrein-Related Peptidases in Biological Fluids by Multiplatform Targeted Mass Spectrometry Assays., PMID:27371727
Stromal TGF-β signaling induces AR activation in prostate cancer., PMID:25333263
Paclitaxel resistance and multicellular spheroid formation are induced by kallikrein-related peptidase 4 in serous ovarian cancer cells in an ascites mimicking microenvironment., PMID:23451143
Inflammation-mediated abrogation of androgen signaling: an in vitro model of prostate cell inflammation., PMID:22911881
Comparative biomarker expression and RNA integrity in biospecimens derived from radical retropubic and robot-assisted laparoscopic prostatectomies., PMID:20615888
Polyclonal antibodies against kallikrein-related peptidase 4 (KLK4): immunohistochemical assessment of KLK4 expression in healthy tissues and prostate cancer., PMID:20180634
Kallikrein-related peptidase 4: a new activator of the aberrantly expressed protease-activated receptor 1 in colon cancer cells., PMID:20056842
Compartmentalized expression of kallikrein 4 (KLK4/hK4) isoforms in prostate cancer: nuclear, cytoplasmic and secreted forms., PMID:16322328
Human kallikrein 4: quantitative study in tissues and evidence for its secretion into biological fluids., PMID:15961548
Kallikrein 4 is a predominantly nuclear protein and is overexpressed in prostate cancer., PMID:15059887
Characterization of KLK4 expression and detection of KLK4-specific antibody in prostate cancer patient sera., PMID:12370833
Detection of human kallikrein 4 in healthy and cancerous prostatic tissues by immunofluorometry and immunohistochemistry., PMID:12142379
Human kallikrein 4 (KLK4) is highly expressed in serous ovarian carcinomas., PMID:11489814
For research use only. Not for human or drug use.
